Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

August 29, 2017

Medtronic, Boston Scientific among investors in Calif. company

Boston Scientific's headquarters in Marlborough. The company was one of several to invest in a California company hoping to develop an inflammation treatment therapy.

Two Central Mass. manufacturers of medical devices have helped contribute $30 million to a California biomedical company looking to develop a bioelectronic therapy for chronic inflammatory diseases.

Medtronic, a Dublin-based medical device maker with an office in Littleton and Marlborough-based medical tech giant Boston Scientific were among several investors helping providing Series D funding for SetPoint Medical’s development.

SetPoint, based in Valencia, Calif., is developing a bioelectronic medicine platform using a small implanted device activating the body’s natural inflammatory reflex and produces anti-inflammatory effects previously only possible by drugs, according to a press release. 

The amount each company invested was not available Tuesday.

Sign up for Enews

WBJ Web Partners

0 Comments

No More articles left

To read more, please
Login or Register (free)

 

To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy

Allow Cookies